Cyprium Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has Cyprium Therapeutics raised to date?

Cyprium Therapeutics has raised obfuscated.

Overview

Cyprium Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cyprium Therapeutics

CB Rank

66603

Cyprium Therapeutics focuses on the development of novel therapies treatment for Menkes disease and related copper metabolism disorders.

Founded

obfuscation

Private

Grant

New York, New York, United States

11-50

www.cypriumtx.com

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Lung S. Yam: Co-Founder, Chief Executive Officer
Michael Weiss: Co-Founder and Director

Details

Legal Name

Cyprium Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Lindsay Rosenwald, Lung S. Yam, Michael Weiss

About the Company

Cyprium Therapeutics focuses on the development of novel therapies treatment for Menkes disease and related copper metabolism disorders. The company was founded in 2017 and is headquartered in New York, United States.

Contact Email

info@cypriumtx.com

Predictions & Insights

Growth Insight

See this Growth Insight

Cyprium Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

CUTX-101 (Copper Histidinate)

A subcutaneous injectable formulation of Copper Histidinate developed to treat Menkes disease by restoring copper levels in patients.

AAV-ATP7A Gene Therapy

An adeno-associated virus (AAV)-based gene therapy designed to deliver functional copies of the ATP7A copper transporter gene for Menkes disease treatment.

Research & Development

Cyprium Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant
obfuscated obfuscation	Grant - Cyprium Therapeutics	1	obfuscated obfuscation	National Institute of Neurological Disorders and Stroke	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Neurological Disorders and Stroke	Yes	Grant - Cyprium Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Cyprium Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Cyprium Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Cyprium Therapeutics	—
National Institute of Neurological Disorders and Stroke	Yes	Grant - Cyprium Therapeutics	—